Project Number 5R01NS112503-03 Agency/Funding Organization NINDS Funding Year 2022 View Full Project Details for Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 5. Other Proteinopathies b. TDP-43 and FUS Researcher and Organization Principal Investigator CLEVELAND, DON W Principal Investigator First Name DON W Principal Investigator Last Name CLEVELAND Awardee Organization LUDWIG INSTITUTE FOR CANCER RES LTD Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PA-19-056: Research Project Grant (Parent R01 Clinical Trial Not Allowed) FY Overall Cost $797,269 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official GUBITZ, AMELIE
